A Review on Formulation and Evaluation of Sustained Release Tablet of Devilproex Sodium

Authors

  • , Kusum
  • Avinash Kumar Gupta
  • Manish Kumar Gupta
  • Vijay Sharma

Abstract

An appropriately designed drug delivery system can be a major step towards solving these two problems. This technique for the drug   administration is termed as ‘sustained release’ or ‘controlled release.  Drugs  with  dosage  not  exceeding  125mg  –  325mg  are  more  suited  as  extended  release  products in order to limit the size of the delivery system.   In  the  case  of  soluble  matrix  the  matrix  swells  or  dissolves.  These matrices then undergo surface erosion with little or no bulk erosion. Divalproex sodium dissociates to the valproate ion in the gastrointestinal tract. The mechanisms by which valproate exerts its therapeutic effects have not been established. One of its most important characteristics is the high gelation velocity and viscosity, which has a significant effect on the release kinetics of the incorporated drug. It was proven that HPMC at high concentration promoted the drug release approaching to a zero-order release kinetic because of its gelation properties

Keywords: HPMC, Divalproex sodium, sustained release and zero-order release kinetic

DOI

https://doi.org/10.22270/jddt.v9i4.3067

Published

2019-07-15
Statistics
Abstract Display: 787
PDF Downloads: 920

How to Cite

1.
Kusum , Gupta AK, Gupta MK, Sharma V. A Review on Formulation and Evaluation of Sustained Release Tablet of Devilproex Sodium. J. Drug Delivery Ther. [Internet]. 2019 Jul. 15 [cited 2026 Jan. 21];9(4):660-2. Available from: https://www.jddtonline.info/index.php/jddt/article/view/3067

How to Cite

1.
Kusum , Gupta AK, Gupta MK, Sharma V. A Review on Formulation and Evaluation of Sustained Release Tablet of Devilproex Sodium. J. Drug Delivery Ther. [Internet]. 2019 Jul. 15 [cited 2026 Jan. 21];9(4):660-2. Available from: https://www.jddtonline.info/index.php/jddt/article/view/3067